Previous close | 0.0300 |
Open | 0.1000 |
Bid | 0.0000 |
Ask | 0.7500 |
Strike | 5.00 |
Expiry date | 2024-05-17 |
Day's range | 0.0300 - 0.1000 |
Contract range | N/A |
Volume | |
Open interest | 7 |
Arbutus Biopharma ( NASDAQ:ABUS ) First Quarter 2024 Results Key Financial Results Revenue: US$1.53m (down 77% from 1Q...
Insights into Arbutus Biopharma Corp's Q1 performance, including financial updates and progress in clinical trials.
Insights into Arbutus Biopharma's First Quarter Performance and Strategic Updates